Drs. Del Rosso and Cotter discuss advances in the molecular understanding of prurigo nodularis, which have enabled the development of targeted pharmaceuticals that treat the root of this condition.
Drs. Del Rosso and Cotter discuss advances in the molecular understanding of prurigo nodularis, which have enabled the development of targeted pharmaceuticals that treat the root of this condition.
David Cotter, MD, PhD, a board-certified dermatologist at Las Vegas Dermatology in Las Vegas, Nevada, discusses a patient case of prurigo nodularis and related trial
Dr. Murase discusses the symptoms and presentation of prurigo nodularis and highlights recent research that demonstrates the effectiveness of nemolizumab for treating patients with this
Dr. Dasilva discusses a case series that demonstrated the marked efficacy of nemolizumab in patients with treatment-resistant chronic pruritus. Reference: Dasilva D, Soto-González A, Mollanazar
JCAD
Journal of Clinical and Aesthetic Dermatology
©2026 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.